Nektar Therapeutics P/CF Ratio 2011-2025 | NKTR

Annual P/CF Ratio Nektar Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.868	-0.856	-4.94	-11.2	-10	10.4	-143	-13.3	-21.4	-12.2	-38	-6.95	-5.84

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.4	-143	-19.8

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	-7.92	$ 3.56	-2.51 %	$ 1.05 B	Canada
AC Immune SA ACIU	-4.64	$ 2.82	-2.07 %	$ 229 M	Schweiz
ADiTx Therapeutics ADTX	-0.00353	$ 3.05	4.81 %	$ 40.2 K	USA
Aeterna Zentaris AEZS	-4.82	-	5.93 %	$ 314 M	Canada
Abeona Therapeutics ABEO	-4.04	$ 4.81	-1.23 %	$ 103 M	USA
ARCA biopharma ABIO	-8.36	-	1052.0 %	$ 415 M	USA
Applied Genetic Technologies Corporation AGTC	-0.64	-	-	$ 26.5 M	USA
Akouos AKUS	-2.7	-	0.23 %	$ 488 M	USA
Amneal Pharmaceuticals AMRX	6.19	$ 11.96	0.13 %	$ 3.7 B	USA
Axcella Health AXLA	-0.359	-	-16.42 %	$ 249 M	USA
Acer Therapeutics ACER	-0.401	-	2.71 %	$ 14 M	USA
Atreca BCEL	-0.607	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	-0.696	-	-2.5 %	$ 5.88 M	USA
argenx SE ARGX	-22.7	$ 901.39	-1.59 %	$ 25 B	Niderland
Armata Pharmaceuticals ARMP	-2.81	$ 5.88	1.03 %	$ 212 M	USA
Achieve Life Sciences ACHV	-3.69	$ 4.69	-1.88 %	$ 93 M	USA
BioDelivery Sciences International BDSI	7.5	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-1.8 K	-	0.49 %	$ 251 B	Cayman-islands
Acorda Therapeutics ACOR	-1.2	-	-24.86 %	$ 820 K	USA
Ascendis Pharma A/S ASND	-17.6	$ 206.12	-1.18 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	-94.9	$ 3.36	-1.95 %	$ 8.08 B	Australia
Autolus Therapeutics plc AUTL	-2.05	$ 1.54	-1.92 %	$ 393 M	Britain
Acasti Pharma ACST	-2.73	-	4.01 %	$ 150 M	Canada
Bellerophon Therapeutics BLPH	-4.42	-	-74.18 %	$ 955 K	USA
Adaptimmune Therapeutics plc ADAP	-14.6	-	-15.15 %	$ 60.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	11.6	-	-	$ 40.3 B	USA
Baudax Bio BXRX	-0.028	-	0.59 %	$ 63 K	USA
AbbVie ABBV	18.2	$ 226.39	-1.0 %	$ 400 B	USA
Cara Therapeutics CARA	-0.588	-	-3.03 %	$ 260 M	USA
CymaBay Therapeutics CBAY	-47.3	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	-0.024	-	-	$ 3.74 B	USA
Codiak BioSciences CDAK	-3.23	-	-55.98 %	$ 2.15 M	USA
Adaptive Biotechnologies Corporation ADPT	-12.4	$ 15.13	-13.34 %	$ 2.23 B	USA
BioLineRx Ltd. BLRX	-57.4	$ 3.37	3.47 %	$ 908 M	Israel
Avid Bioservices CDMO	38.7	-	-	$ 789 M	USA
Biogen BIIB	6.73	$ 182.61	0.35 %	$ 26.6 B	USA
Cerevel Therapeutics Holdings CERE	-19.5	-	-	$ 7.29 B	USA
ContraFect Corporation CFRX	-0.0235	-	-5.16 %	$ 5.39 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-3.88	-	-1.52 %	$ 24.7 M	USA
Beam Therapeutics BEAM	-7.21	$ 27.45	-5.05 %	$ 2.26 B	USA
BioMarin Pharmaceutical BMRN	22.9	$ 53.01	-1.51 %	$ 10.1 B	USA
BioNTech SE BNTX	70.7	$ 96.12	0.13 %	$ 27.2 B	Germany
Clearside Biomedical CLSD	-5.59	-	-	$ 25.3 M	USA
Celsion Corporation CLSN	-1.12	-	-6.63 %	$ 13.9 M	USA
Clovis Oncology CLVS	-1.18	-	-7.23 %	$ 13 M	USA
Advaxis ADXS	-0.0633	-	-9.65 %	$ 45.9 M	USA
Checkmate Pharmaceuticals CMPI	-0.982	-	-	$ 231 M	USA
Chimerix CMRX	-1.5	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	-1.87	-	-	$ 401 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-10.3	$ 9.44	-1.82 %	$ 611 M	USA